Table 2.
Baby | Child Baseline CD4 | Child Baseline VL | Age at first AZT/NVP dose (Hours)* | Age at Screening (Hours) | Point-of-Care Result |
---|---|---|---|---|---|
A | 5,159 | 1,661 | 114.5 | 18.5 | Negative |
B | 1,995 | 17,244 | 25.3 | 13.6 | Positive |
C | 1,854 | 1,636 | 21.3 | 25.5 | Positive |
D | 1,021 | 1,111,950 | 7.0 | 15.9 | Positive |
E | 1,556 | 1,375 | 2.4 | 9.8 | Positive |
F | 1,748 | >10,000,000 | 29.9 | 6.6 | Positive |
G | 1,634 | <40 | 0.2‡ | 39.2 | Positive |
H | 1,950 | 60,247 | 3.5 | 19.9 | Positive |
I | 1,671 | 3,145 | 4.2 | 40.1 | Positive |
J | 2,616 | 1,005 | 1.6 | 44.8 | Positive |
K | 2,177 | 272 | 23.0 | 36.5 | Positive |
L | 1,066 | 1,314 | 0.2‡∞ | 32.0 | Positive |
M | 1,469 | 23,686 | 0.7∞ | 6.6 | Positive |
N | 1,601 | 20,291 | 27.3 | 14.2 | Positive |
O | --- | --- | --- | --- | Positive |
Median | 1,709.5 | 2,403 | 5.6 | 19.2 |
Single-dose NVP (10–15 mg PO) and daily AZT (4mg/kg PO twice daily)
Time estimated based on delivery
Infant did not receive NVP